Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy DOI Creative Commons

Arupam Patra,

Arisha Arora, Siddhartha Sankar Ghosh

et al.

ACS Pharmacology & Translational Science, Journal Year: 2024, Volume and Issue: 7(9), P. 2878 - 2893

Published: Sept. 3, 2024

Metastasis stands as a prime contributor to triple-negative breast cancer (TNBC) associated mortality worldwide, presenting heightened severity and significant challenges due limited treatment options. Addressing TNBC metastasis necessitates innovative approaches novel therapeutics specifically target its propensity for dissemination distant organs. Targeted therapies capable of reversing epithelial-to-mesenchymal transition (EMT) play crucial role in suppressing enhancing the response. Beauvericin, promising fungal secondary metabolite, exhibits potential diminishing viability EMT-induced cells by triggering intracellular oxidative stress, evidenced an enhanced reactive oxygen species level reduced mitochondrial transmembrane potential. In monolayer cultures, it has exhibited IC

Language: Английский

Involvement of LaeA and Velvet Proteins in Regulating the Production of Mycotoxins and Other Fungal Secondary Metabolites DOI Creative Commons

Xuwen Hou,

Liyao Liu,

Dan Xu

et al.

Journal of Fungi, Journal Year: 2024, Volume and Issue: 10(8), P. 561 - 561

Published: Aug. 8, 2024

Fungi are rich sources of secondary metabolites agrochemical, pharmaceutical, and food importance, such as mycotoxins, antibiotics, antitumor agents. Secondary play vital roles in fungal pathogenesis, growth development, oxidative status modulation, adaptation/resistance to various environmental stresses. LaeA contains an S-adenosylmethionine binding site displays methyltransferase activity. The members velvet proteins include VeA, VelB, VelC, VelD VosA for each member with a domain. can form multimeric complexes VosA-VelB VelB-VeA-LaeA. They belong global regulators mainly impacted by light. One their most important functions is regulate gene expressions that responsible metabolite biosynthesis. aim this mini-review represent the newest cognition biosynthetic regulation mycotoxins other proteins. In cases, positively production metabolites. regulated species toxigenic fungi from genera Alternaria, Aspergillus, Botrytis, Fusarium, Magnaporthe, Monascus, Penicillium mycotoxins. We control inhibit harmful while promoting useful fungi. Furthermore, should be practical strategy activating silent clusters (BGCs) obtain previously undiscovered

Language: Английский

Citations

6

Regulation of LaeA and Velvet Proteins on the Production of Mycotoxins and Other Fungal Secondary Metabolites DOI Open Access

Xuwen Hou,

Liyao Liu,

Dan Xu

et al.

Published: July 16, 2024

Fungi are rich sources of secondary metabolites agrochemical, pharmaceutical and food importances, such as mycotoxins, antibiotics antitumor agents. Secondary play vital roles in fungal pathogenesis, growth development, oxidative status modulation, adaptation/resistance to various environmental stresses. LaeA contains an S-adenosylmethionine binding site displays methyltransferase activity. The members velvet proteins include VeA, VelB, VelC, VelD VosA, for each member with a domain. can form multimeric complexes VosA-VelB VelB-VeA-LaeA. They belong global regulators mainly impacted by light. One their most important functions is regulate gene expression that responsible metabolite biosynthesis. aim this mini-review represent the newest cognition on biosynthetic regulation mycotoxins other proteins. In cases, positively regulated production metabolites. species toxigenic fungi from genera Alternaria, Aspergillus, Botrytis, Fusarium, Magnaporthe, Monascus, Penicillium mycotoxins. We control inhibit harmful while promoting useful fungi. Furthermore, should be practical strategy activating silent clusters (BGCs) obtain previously undiscovered

Language: Английский

Citations

4

Leveraging endophytic fungi and multiomics integration for targeted drug discovery DOI
Aleena James Chirayimmel, Gursharan Kaur, Swapnil Kajale

et al.

Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown, P. 277 - 293

Published: Jan. 1, 2025

Language: Английский

Citations

0

Genome mining of an endophytic natural yeast isolate Rhodotorula sp. Y090 and production of the antioxidant ergothioneine DOI

Yu-Zhen Li,

Qi Wang, Cheng Cheng

et al.

Journal of Biotechnology, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Language: Английский

Citations

0

l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development DOI
Sukanya Sonowal, Kalyani Pathak, Dibyajyoti Das

et al.

Advanced Therapeutics, Journal Year: 2024, Volume and Issue: 7(10)

Published: Aug. 19, 2024

Abstract Cancer remains a persistent global health concern, representing significant challenge in medical science and patient care. In this context, l ‐asparaginase has emerged as promising therapeutic agent due to its unique ability deplete circulating asparagine, thereby selectively targeting cancer cells. However, despite potential, current formulations of are not without limitations. Issues such immunogenicity, short half‐life, variable efficacy present hurdles widespread clinical application. To overcome these hurdles, researchers focusing on developing bio‐better versions ‐asparaginase. These bio‐betters aim enhance stability, reduce optimize enzyme kinetics, thus improving treatment outcomes. This review critically assesses the landscape bio‐betters, offering insights into ongoing advancements, optimization strategies, future bio‐engineering frontiers. It discusses modifications properties explores innovative approaches like in‐silico engineering artificial intelligence, highlighting their potential improve profile Challenges debates surrounding mechanism also addressed. By addressing challenges outlining directions, aims contribute advancement anti‐cancer therapeutics, particularly context research.

Language: Английский

Citations

2

Beauvericin Reverses Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through Regulation of Notch Signaling and Autophagy DOI Creative Commons

Arupam Patra,

Arisha Arora, Siddhartha Sankar Ghosh

et al.

ACS Pharmacology & Translational Science, Journal Year: 2024, Volume and Issue: 7(9), P. 2878 - 2893

Published: Sept. 3, 2024

Metastasis stands as a prime contributor to triple-negative breast cancer (TNBC) associated mortality worldwide, presenting heightened severity and significant challenges due limited treatment options. Addressing TNBC metastasis necessitates innovative approaches novel therapeutics specifically target its propensity for dissemination distant organs. Targeted therapies capable of reversing epithelial-to-mesenchymal transition (EMT) play crucial role in suppressing enhancing the response. Beauvericin, promising fungal secondary metabolite, exhibits potential diminishing viability EMT-induced cells by triggering intracellular oxidative stress, evidenced an enhanced reactive oxygen species level reduced mitochondrial transmembrane potential. In monolayer cultures, it has exhibited IC

Language: Английский

Citations

0